NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two commercial brands. Quell is a wearable neuromodulation platform. DPNCheck is a point-of-care screening test for peripheral neuropathy. It operates two product categories: Diagnostic technology and Therapeutic technology. Diagnostic technology product category is engaged in point-of-care peripheral neuropathy assessment. Therapeutic technology product category is engaged in wearable neuromodulation for chronic pain syndromes. Its patients control and personalize the technology via a mobile phone application, and their utilization and certain clinical metrics may be tracked in the Quell Health Cloud.

• Revenue in USD (TTM)4.38m
• Net income in USD-7.94m
• Incorporated2001
• Employees26.00

• Location
  NeuroMetrix Inc1000 Winter StreetWALTHAM 02451United StatesUSA
• Phone+1 (781) 890-9989
• Fax+1 (302) 636-5454
• Websitehttps://www.neurometrix.com/